Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.
نویسندگان
چکیده
منابع مشابه
Radioiodine treatment of multinodular non-toxic goitre.
OBJECTIVE To investigate the long term effect of radioactive iodine on thyroid function and size in patients with non-toxic multinodular goitre. DESIGN Consecutive patients with multinodular non-toxic goitre selected for radioactive iodine treatment and followed for a minimum of 12 months (median 48 months) after an intended dose of 3.7 MBq/g thyroid tissue corrected to a 100% uptake of iodin...
متن کاملThyroid cancer in toxic and non-toxic multinodular goiter.
BACKGROUND Many authors have claimed that hyperthyroidism protects against thyroid cancer and believed that the incidence of malignancy is lower in patients with toxic multinodular goiter (TMG) than in those with non-toxic multinodular goiter. But in recent studies, it was reported that the incidence of malignancy with TMG is not as low as previously thought. AIM To compare the thyroid cancer...
متن کاملSerum TSH and the response to radioiodine treatment of toxic multinodular goitre.
A retrospective analysis of data from 73 consecutive patients with toxic multinodular goitre treated with iodine-131 (131I) during a 2-year period was performed to investigate if serum TSH at the time of 131I treatment influences the outcome. The dose of 131I was calculated according to a model compensating for thyroid size estimated by palpation and 24-h 131I uptake. Serum TSH was determined b...
متن کاملEvaluating and managing patients with thyrotoxicosis.
BACKGROUND Thyrotoxicosis is common in the Australian community and is frequently encountered in general practice. Graves disease, toxic multinodular goitre, toxic adenoma and thyroiditis account for most presentations of thyrotoxicosis. OBJECTIVE This article outlines the clinical presentation and evaluation of a patient with thyrotoxicosis. Management of Graves disease, the most frequent ca...
متن کاملMultinodular Thyroid Disease
Multinodular goitre is the most prevalent thyroid pathological abnormality worldwide, although its geographical incidence varies greatly according to environmental iodization Most countries in central and southern Europe have endemic goitre areas with a prevalence of multinodular goitre (MG) of 3-6%. In United States, the annual incidence of nodular thyroid disease is 0.1% to 1.5% and the preva...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- BMJ
دوره 297 6649 شماره
صفحات -
تاریخ انتشار 1988